What is Orion Infusions Price-to-Operating-Cash-Flow?
As of today (2025-06-25), Orion Infusions's share price is BDT310.20.
Orion Infusions's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was BDT0.13. Hence, Orion Infusions's Price-to-Operating-Cash-Flow Ratio for today is 2,481.60.
The historical rank and industry rank for Orion Infusions's Price-to-Operating-Cash-Flow or its related term are showing as below:
DHA:ORIONINFU'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.67 Med: 40.91 Max: 3168
Current: 2464
During the past 13 years, Orion Infusions's highest Price-to-Operating-Cash-Flow Ratio was 3168.00. The lowest was 9.67. And the median was 40.91.
Orion Infusions's Cash Flow from Operations per share for the
three
months ended in Mar. 2025 was BDT0.97.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was BDT0.13.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Orion Infusions was -97.80% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 26.30% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -2.00% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -1.20% per year.
During the past 13 years, Orion Infusions's highest 3-Year average Operating Cash Flow per Share Growth Rate was 92.00% per year. The lowest was -61.30% per year. And the median was -0.30% per year.
Orion Infusions Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Orion Infusions's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Infusions Price-to-Operating-Cash-Flow Chart
|
Orion Infusions Annual Data
|
|
Trend |
Jun15 |
Jun16 |
Jun17 |
Jun18 |
Jun19 |
Jun20 |
Jun21 |
Jun22 |
Jun23 |
Jun24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
23.99 |
48.86 |
39.11 |
112.92 |
170.27 |
|
Orion Infusions Quarterly Data
|
|
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
Dec24 |
Mar25 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
92.05 |
170.27 |
119.40 |
189.48 |
3,133.60 |
Competitive Comparison of Orion Infusions's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Orion Infusions's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Infusions's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orion Infusions's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Orion Infusions's Price-to-Operating-Cash-Flow falls into.
Orion Infusions Price-to-Operating-Cash-Flow Calculation
Orion Infusions's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 310.20 | / | 0.125 |
| = | 2,481.60 |
Orion Infusions's Share Price of today is BDT310.20.
Orion Infusions's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0.13.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Orion Infusions Business Description
Traded in Other Exchanges
N/A
Address
153-154 Tejgaon I/A, Orion House, Dhaka, BGD, 1208
Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.
Orion Infusions Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DHA:ORIONINFU has been successfully added to your